chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Case previously recorded as MA2009-5170. Initial case report received from a physician, via Novartis Medical Communication on 20 NOV 2009. A 2 year-old female patient was vaccinated with S-OIV FOCETRIA (batch no. 102124P1, expiration date 31 MAR 2010) i.m. on 13 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-008308.
Shortness of breath, headache,  chest tightness,  lung pain,  weakness, hotness.  Went to the ER, chest xray done. Lungs clear. Took only ibuprofen.
First night and next day felt the expected bad feelings and lack of energy. Cleared up by Monday August 9 2021. Then 1-2 days later I started having odd feelings in my heart. As someone who vapes nicotine I know my body is used to it yet the smallest bit of a hit from the vape made my heart race. I also noticed this occur without having vaped or anything. Sometimes just sitting there I would notice it increase. I also got the worst sinus infection ever and felt completely blocked up. There were a couple days where I would blow my nose and could feel it hurt my teeth. After a couple days maybe about a week I felt the sinus infection alleviate. However the heart issue persisted for a couple more days. Now it?s all done and I can vape and take my adderall like before.
This spontaneous report as received from a nurse refers to a patient of unknown gender and age. Information regarding the patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On 21-JUN-2005 the patient was vaccinated with an expired dose of VARIVAX (lot # 0689N, expiry date: 14-MAY-2005) which was reconstituted with a sterile diluent (lot # and expiry date unknown) for prophylaxis. No adverse effects were reported.
fatigue, headache, muscle pain, join pain, chills most of the day after the shot, some minor fatigue and chills the 2nd day.  All was fine after that.
Pt vaccinated with MMR/HIB developed fussiness, clinginess & increased sleepiness. Evaluated in office 12SEP without other signs suggestive of infection date of immunization 30AUG90
This spontaneous report was received from a pharmacist refers to a 55 year old female patient. No medical history was reported. On 08-JUN-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiry, dose, route not reported). Concomitant therapies included ESTRING and vitamin d (unspecified). On an unknown date in June 2013, the patient had swelling and redness at the injection site. Pharmacist stated he was currently filling a prescription from the patient's unspecified healthcare provider for a MEDROL dose pack. Patient sought medical attention- saw her unspecified primary care provider. The outcome of she had swelling and redness at the injection site was reported as not recovered. Additional information is not expected.
Patient was given 0.5ml instead of 0.25ml, he was called and denies any problems since being vaccinated, letter was also sent to patient.
5cm x 4.5cm circular reddened area on left posterior upper arm. Area warm to the touch and slightly raised. Service member c/o mild tenderness at site, denied fever or drainage.
Redness, swelling at injection site, warm to touch, sore, painful to touch.
COVID-19; COVID-19; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar events for 2 patients. This is the first of two reports.   A 13-year-old patient of an unspecified gender received the first dose of BNT162B2 (BNT162B2, Manufacturer Pfizer-BioNTech) via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient became COVID-19 positive two weeks after first dose. The patient showed minimal symptoms. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on unspecified date 2 weeks after vaccination. Clinical outcome was unknown at time of this report.   The lot number for BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events drug ineffective and COVID-19 cannot be totally excluded .,Linked Report(s) : US-PFIZER INC-202101172409 same reporter, product and AE, different patient
I had a major headache and pressure in eyes directly after injection. On the morning of day two I had pressure in the eyes with bleeding coming from what I believe was the tear ducts. I also had bruising that occurred all over my body. The bleeding of the eyes came back about a week after the injection.  It has not happened since.
Patient is a 32 y.o. G3P3 female patient of MD with a history of SVD following IOL for severe PreE. Delivery complicated by PPH 2/2 retained placenta and lovenox VTE ppx for COVID-19 infection.    Pt received Mg ppx up until 24hrs postpartum without complication. S/p Venofer 400mg x2 prior to discharge. Discharge Hgb reviewed and trending up prior to discharge. Transaminitis resolving. Normal range BP since approx 8p DOD.    Continue iron, ibuprofen, tylenol, and colace at discharge. Resume lovenox and ASA for covid-19 until 9/21/23.     Discharge Diagnoses:   38 weeks gestation pregnancy  Severe pre-eclampsia with delivery  COVID-19 affecting childbirth  Postpartum hemorrhage Blood loss anemia Retained placenta  Lactating mother
This case was received from a other health professional and described the occurrence of accidental overdose in a 18-year-old male patient who received ENGERIX B adult. In December 2014, the patient received ENGERIX B adult. On an unknown date, an unknown time after receiving ENGERIX B adult, the patient experienced accidental overdose. On an unknown date, the outcome of the accidental overdose was unknown.
Pt recvd 1st dose of Hep B vax on 6FEB91 & exp abdominal discomfort which remitted spontaneously;
Patient developed a temperature of 10; warmth, redness, and hard left arm; frontal headache; period of syncope. Patient was started on Clindamycin HCL 300 mg Q.I.D. x 4 days.
Achiness; Vomiting; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achiness), VOMITING (Vomiting) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, the patient experienced MYALGIA (Achiness), VOMITING (Vomiting) and HEADACHE (Headache). At the time of the report, MYALGIA (Achiness), VOMITING (Vomiting) and HEADACHE (Headache) was resolving.            Products known to have been used by the patient, within two weeks prior to the event, included unspecified migraine medication. Treatment medication included Paracetamol.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.
2 days after 2 nd  Modena vaccine injection  the following  began:   Acute diarrhea with sharp gut pain on 10 of 10 scale lasting 2 to 3 hours. In the next 2 days to 2 weeks that  followed I had  nausea, daily headache, changes in bowel movement, incontinence, blood clots  and fleshy matter and mucous continued for 2 weeks then clot diminished however bleeding and fleshy matter and mucous continued occurring along with daily headaches and anal pain and bowel urgency and incontinence continued and  having a variety of bowel movements 3-4 times daily. Increased gas with blood. Blood in stool was sometimes bright red and other times maroon. Stool varies from soft,  loose,  diarrhea  and small in size.  This has continued to the present. I have been tested by my PCP. I have a colonoscopy on Jan 11 2021
Adverse event developed approximately 8 hours after vaccine.  Onset of the expected chills/fever to 102/body aches/headache.  But right wrist began to swell.  Shot was given in left arm.  Over the course of next 2 days wrist  became more swollen, unable to move fingers/wrist and lower arm on right without pain. On day 2 unable to make a fist at all.   Slowly over 7 days the swelling and pain diminished, however ongoing soreness at right wrist persists.
LEFT CHEST PAIN; This spontaneous report received from a patient concerned a 62 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, and high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-APR-2021 09:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-APR-2021 14:00, the subject experienced left chest pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of left chest pain was not reported. This report was non-serious.
SORE THROAT, RUNNY NOSE, SNEEZING, HEADCAHE, FEVER, BODYACHE, SINUS PRESSURE, GENERALIZED MALAISE (got flu within 24 hours of getting Flu shot, spread it to other family members, resulted in unnecessary use of meds during first trimester of pregnancy).
Information has been received from a physician concerning a male patient who an unknown date was vaccinated with a dose of RECOMBIVAX HB (manufacturer unknown). Subsequently the patient developed unspecified muscle problems. The physician stated that the muscle problem was not Guillain Barre Syndrome. The patient sought unspecified medical attention. At the time of the report, the outcome of the patient was unknown. No further information is available.
On 8/12/02 noticed tingling of nose, fingers and tips of toes. Went to MD on 11/2/02. Still experiencing symptoms.
Left lower eyelid twitch; Fatigue; Soreness/pain at injection site; Fever; hives improved since receiving Shingrix; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included bug bite (presumed bug bite). Concurrent medical conditions included hives (around one year ago she began having widespread hives on a daily basis due to a presumed bug bite). Concomitant products included cetirizine hydrochloride (Zirtec).   On 10th January 2023, the patient received the 1st dose of Shingrix (intramuscular). On 10th January 2023, 12 hrs after receiving Shingrix, the patient experienced injection site pain, fever and fatigue. On 11th January 2023, the patient experienced eyelid twitching. In January 2023, the patient experienced unexpected therapeutic effect. On 11th January 2023, the outcome of the injection site pain was recovered/resolved. On 12th January 2023, the outcome of the fever and fatigue were recovered/resolved. On 21st January 2023, the outcome of the eyelid twitching was recovered/resolved. On an unknown date, the outcome of the unexpected therapeutic effect was unknown.   It was unknown if the reporter considered the injection site pain, fever, eyelid twitching and fatigue to be related to Shingrix.     Additional Information: GSK Receipt Date: 31-JAN-2023 Reporter's Comment: The case was self reported by the patient. The patient reported that around one year ago she began to have widespread hives on a daily basis due to a presumed bug site and for that she had to take Zirtec approximately every 2 to 2.5 days since that time. The patient received first dose of Shingrix and reported that her hives dramatically improved since receiving Shingrix and that she not had to use a Zirtec since 11th January 2023. The patient also reported side effects of the vaccine such as fatigue, fever, soreness or pain at the injection site and an eye twitching began very shortly after injection within 12 hours. All symptoms lasted only one day, except the unexpected benefit, which was the true reason for her call and continued.   The reporter consented to follow up.
About 4 months after the third dose of my COVID-19 vaccine my wife had tested Positive for Covid-19 and then I came down with it. I had a cough and some fatigue. I was prescribed Paxlovid immediately after testing positive at a clinic. I started to feel better pretty quickly. I tested negative after five days. About five days after testing negative my symptoms rebounded and they were little more severe, but they were still relatively moderate. I took some decongestant and a cough suppressant and I recovered after about a week.
7cm x 4 cm area of redness and induration on right buttock surrounding injection site (local reaction only) no pain, is pruitic.
Patient vaccinated with first series of moderna covid19 vaccinator on 12/27/20. He had had a close case contact with someone on 12/25 who later became symptomatic and covid19 posits He developed congestion starting 12/30.  No other symptoms. These symptoms are ongoing
Day of injection: soreness at injection site. Next day: 4 inch diameter red spot with smooth large raised lump same size same site. Starting three days post injection: lump swelling started to dissipate, site became very red with 4 inch diameter and itchy. 10 days post injection: site is only slightly itchy and pink, definitely improving. Treatment: anti-histamine oral Allegra and Benadryl cream. Home self-care, did not contact Dr..
Pt. voiced no adverse events  Nurse Mgr/APRN at Co. Health Dept. discovered that the above mentioned Pfizer vaccine was not properly removed from the regular freezer (-25 degrees Celsius to -15 degrees Celsius) on 10/13/2021. The Pfizer vaccine was moved from ultra cold freezer to regular freezer on 09/28/21 and should have been removed from the regular freezer the end of the day on 10/13/2021 and placed in the refrigerator for 31 days. The vaccine was not removed on this day from the freezer. The vaccine is still in the freezer today 10/25/2021. It was investigated and found that the vaccine was use in clinic Monday 10/18 through 10/23. NP called Pfizer and spoke to an attendant, walked her through the scenario and she made NP aware that vaccine could not be used past day 17 after being in the regular freezer, voice that vaccine stability could not be determined and that vaccine should not have been used past the 3 day grace or day 17 and should have been moved to the refrigerator on day 14 after removed from regular freezer. Patient was notified of the incident.
flu-like symptoms for a day or two; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms for a day or two) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Epididymitis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms for a day or two). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms for a day or two) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. Treatment medication included antibiotics.   This case was linked to MOD-2021-369197 (Patient Link).
3 days after injection, swelling upper arm 12"x6" with erythema and warmth. Treated with ice and Depomedrol 80mg 1M.
New onset of seizure less than 24 hours after 1st dose. Heart palpitations/increased heart rate for 7 days post vaccination.
Rt upper arm swollen, red, tender to touch. Use Tylenol/Motrin for pain.
Symptoms started out with rigors and a fever.  This progressed to a diffuse maculopapular rash that resolved within 24 hours.  Following day, he was tachycardic and tachypneic when he presented to the emergency department.  Ultimately he was found to be in septic shock with myopericarditis.  He required pressors.  He is currently still in the hospital
I had a lot of sinus drainage & had a very sore throat. So I took at home COVID-19 test & it was positive. My Dr. prescribed me Paxlovid.
From June 1 midnight, got itchy rashes around my waist mostly, a few of them on arm and right thigh, mid to late June, rashes move to both feet and left leg, July 4th, move to right leg. late June, there are 31 rashes on right leg. Some of the rashes become blisters. The rashes/blisters heal themselves in 2 weeks mostly, but it reoccurs at different place of the body till now, and so sign of stopping. Took Zyrtec or Claritin can ease the itches, touching by hands or clothes made them more itchy.  My daughter (12 years old) has similar symptom two weeks after her first dose, (June 18 first dose of Pfrizer, July 1st rashes started from feet, then to legs.)
Turned pale white, rash on whole of back, weak - couldn't walk, fatigued, migraine headaches, felt like I was dying lasted little over 4 days Still have migraines from time to time that last about 4-6 hours
Vaccination received 1/8/2010. Injection was unusually painful and arm has gotten progressively more painful since then. Upper arm hurts and patient says can barely move it. DX: Injection site tissue inflammation.
Evaluated at health care clinic localized reaction to influenza vaccine; site to be recheck tomorrow apply ice intermittently.
This spontaneous report as received from a pharmacist refers to a 58 year old male patient. On 04-Feb-2013, the patient started vaccination with the first dose of RECOMBIVAX HB (lot # not reported). On 23-OCT-2013 ("today" at the time of report) the patient was vaccinated with the third expired dose of RECOMBIVAX HB, (lot # H017802, Exp date: 06-OCT-2013), 40 mcg/ml, in the right arm, route unspecified. Dialysis patient received 40 mcg dialysis dose of RECOMBIVAX HB. No adverse effects reported at this time. Additional information has been requested.
Approximately 12 hours after being given the shot, I experienced nausea, headache, vomiting and a temperature of 100.2.
Beginning at 1:00 am ,Extreme headache , stomach ache, muscle ache,nausea,  couldn?t sleep. Next day I still had those symptoms , which begun to get less and less by night time
states had 2nd covid vaccine yesterday,  had waves of N yesterday; fever, aches chills overnight, took Tylenol overnight, took melatonin around 12 pm due to difficulty falling asleep this am woke,  took temp -was 99.3, went to bathroom and urinated and then got in shower, felt a little nauseous and starting loosing vision , then fell hitting head on R side
Patient received vaccination at  1359, at 1420, patient c/o  of tightness in her throat and mild wheezing during her 30 minute observation period secondary to previous anaphylactic event from Ibuprofen.  Patient states she has a history of asthma and was recently started on a new rescue inhaler, which she was not in possession of at that time.  VS were taken by RN-BC and EMT and found to be WNL and lung sounds were clear pre auscultation.  Patient was given 12.5 mg of liquid Benadryl per standing order for mobile vaccine clinics.  Patient was observed for approximately 15 to 20 minutes longer, and was discharged home with no further symptoms.  Patient was instructed to use inhaler if wheezing continued or became more severe and to seek medical attention immediately.
Syncope/seizure like activity approximately 5 sec post vaccines. TDaP, MENACTRA, Flu, HPV. Bladder incont., difficult to arouse approximately 15 min., nausea once A/O x 3.
Body aches; sore throat; congestion; fatigue; sore arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Dec2022 at 14:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 42 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Shellfish" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; VITAMIN B COMPLEX. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: Unknown), administration date: Mar2021, for COVID-19 Immunization; Bnt162b2 (DOSE 2, SINGLE; Lot number: Unknown; Anatomical location: Arm Right), administration date: Oct2021, when the patient was 41 years old, for COVID-19 Immunization, reaction(s): "Inappropriate schedule of vaccine administered". The following information was reported: PAIN (non-serious) with onset 07Dec2022, outcome "recovering", described as "Body aches"; NASAL CONGESTION (non-serious) with onset 07Dec2022, outcome "recovering", described as "congestion"; FATIGUE (non-serious) with onset 07Dec2022, outcome "recovering"; PAIN IN EXTREMITY (non-serious) with onset 07Dec2022, outcome "recovering", described as "sore arm"; OROPHARYNGEAL PAIN (non-serious) with onset 07Dec2022, outcome "recovering", described as "sore throat". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain, oropharyngeal pain, nasal congestion, fatigue, pain in extremity.  Additional information: The reporter assessed the event as non-serious. The patient did not receive any other vaccination in 4 weeks. The patient did not had COVID prior to vaccination and was tested for COVID post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201362476 Same patient/Vaccine,different event,different vaccine dose;
Afternoon of the shot: mild body aches, fatigue, headache. Next day - 9/13: body aches gone. Still fatigue, worse headache. Went to bed 4:30pm. Woke up nearly every hour. Got up at 7:30am the next morning (9/14).  Feeling back to normal.
vaccinated and still got/suspected vaccination failure; still got; pain; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient was vaccinated and still got painful shingles. This case was considered as suspected vaccination failure as details regarding the completion of primary vaccination schedule, time to onset and laboratory test confirmation were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
About a week after the shot a noticeable fatigue set in. I need to sleep more and I am tired much more often than usual. I actually fell asleep during a video conference with a colleague.  These symptoms remain consistent to date ... a couple of weeks so far.